What is Seaport Therapeutics 's pre-tax income?

Seaport Therapeutics (SPTX) reported pre-tax income of -$24.89M in Q1 2026.

What does pre-tax income mean?

Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.

Seaport Therapeutics SPTX Pre-Tax Income

Pre-Tax Income at other companies

MYR GroupMYRG

$64.03M+95.4%

Piper SandlerPIPR

$87.93M+199%

RepligenRGEN

$1.77M-77.7%

SSR MiningSSRM

$309.96M+193%

LKQLKQ

$167M-24.1%

Sensata TechnologiesST

$115.5M+27.5%

Other financials

Income statement

See full

Operating income-$27.5M-70.2%

Net income-$25.4M-93.6%

EPS (diluted)-$10.34-83.0%

Balance sheet

See full

Cash & equivalents$52.9M—

Total debt$5.3M—

Total equity-$115.6M-220%

Total assets$227.7M—

Cash flow

See full

Operating cash flow-$20.2M+0.2%

CapEx--100%

Free cash flow-$20.2M+0.4%

Valuation

See full

Market cap$972.65M—

Enterprise value$925.08M—

Returns & leverage

See full

Debt / equity-0×—

Current ratio13.2×—

Where this comes from

Reported directly by Seaport Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The official record: Seaport Therapeutics ’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Seaport Therapeutics 's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Seaport Therapeutics 's pre-tax income?: Seaport Therapeutics (SPTX) reported pre-tax income of -$24.89M in Q1 2026.
What does pre-tax income mean?: Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.